piperacillin tazobactamhttp://www.unboundmedicine.com/medline/ebm/research/piperacillin_tazobactamUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporins.http://www.unboundmedicine.com/medline/ebm/record/19915068/full_citation/Activity_of_mecillinam_against_Escherichia_coli_resistant_to_third_generation_cephalosporins_Wootton M, Walsh TR, Macfarlane L, et al. 
Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporins. [JOURNAL ARTICLE]
J Antimicrob Chemother 2009 Nov 13.
Abstract | Full CitationIn Vitro Synergy of Levofloxacin Plus Piperacillin/Tazobactam against Pseudomonas aeruginosa.http://www.unboundmedicine.com/medline/ebm/record/19911066/full_citation/In_Vitro_Synergy_of_Levofloxacin_Plus_Piperacillin/Tazobactam_against_Pseudomonas_aeruginosa_Chachanidze V, Curbelo-Irizarry A, Ashcraft D, et al. 
In Vitro Synergy of Levofloxacin Plus Piperacillin/Tazobactam against Pseudomonas aeruginosa. [Journal Article]
Interdiscip Perspect Infect Dis 2009.:984934.
Abstract | Full Citation | Find Related Articles Accounting for the Development of Antibacterial Resistance in the Cost Effectiveness of Ertapenem versus Piperacillin/Tazobactam in the Treatment of Diabetic Foot Infections in the UK.http://www.unboundmedicine.com/medline/ebm/record/19908928/full_citation/Accounting_for_the_Development_of_Antibacterial_Resistance_in_the_Cost_Effectiveness_of_Ertapenem_versus_Piperacillin/Tazobactam_in_the_Treatment_of_Diabetic_Foot_Infections_in_the_UK_Jansen JP, Kumar R, Carmeli Y 
Accounting for the Development of Antibacterial Resistance in the Cost Effectiveness of Ertapenem versus Piperacillin/Tazobactam in the Treatment of Diabetic Foot Infections in the UK. [Journal Article]
Pharmacoeconomics 2009; 27(12):1045-56.
Abstract | Full CitationIn vitro susceptibility of Achromobacter spp. isolates: comparison of disk diffusion, Etest and agar dilution methods.http://www.unboundmedicine.com/medline/ebm/record/19889520/full_citation/In_vitro_susceptibility_of_Achromobacter_spp__isolates:_comparison_of_disk_diffusion_Etest_and_agar_dilution_methods_Almuzara M, Limansky A, Ballerini V, et al. 
In vitro susceptibility of Achromobacter spp. isolates: comparison of disk diffusion, Etest and agar dilution methods. [JOURNAL ARTICLE]
Int J Antimicrob Agents 2009 Nov 2.
Abstract | Full Citation | Find Related Articles In vitro activity of tigecycline and comparators against a European compilation of anaerobes collected as part of the Tigecycline Evaluation and Surveillance Trial (TEST).http://www.unboundmedicine.com/medline/ebm/record/19883155/full_citation/In_vitro_activity_of_tigecycline_and_comparators_against_a_European_compilation_of_anaerobes_collected_as_part_of_the_Tigecycline_Evaluation_and_Surveillance_Trial__TEST__Nagy E, Dowzicky MJ 
In vitro activity of tigecycline and comparators against a European compilation of anaerobes collected as part of the Tigecycline Evaluation and Surveillance Trial (TEST). [JOURNAL ARTICLE]
Scand J Infect Dis 2009 Nov 2.
Abstract | Full Citation | Find Related Articles [Analysis on the sensitivity to beta-lactam antibiotics of respiratory-infectious isolates on the second survey on the sensitivity of isolates conducted by the japanese society of chemotherapy in 2007--concerning the aspect of PK/PD break points]http://www.unboundmedicine.com/medline/ebm/record/19882981/full_citation/[Analysis_on_the_sensitivity_to_beta_lactam_antibiotics_of_respiratory_infectious_isolates_on_the_second_survey_on_the_sensitivity_of_isolates_conducted_by_the_japanese_society_of_chemotherapy_in_2007__concerning_the_aspect_of_PK/PD_break_points]Niki Y, Kohno S, Watanabe A, et al. 
[Analysis on the sensitivity to beta-lactam antibiotics of respiratory-infectious isolates on the second survey on the sensitivity of isolates conducted by the japanese society of chemotherapy in 2007--concerning the aspect of PK/PD break points] [English Abstract, Journal Article]
Jpn J Antibiot 2009 Jun; 62(3):203-13.
Abstract | Full Citation[Evolution of antimicrobials resistance against Pseudomonas aeruginosa in a French University Hospital between 2002 and 2006.]http://www.unboundmedicine.com/medline/ebm/record/19875241/full_citation/[Evolution_of_antimicrobials_resistance_against_Pseudomonas_aeruginosa_in_a_French_University_Hospital_between_2002_and_2006_]Minchella A, Molinari L, Alonso S, et al. 
[Evolution of antimicrobials resistance against Pseudomonas aeruginosa in a French University Hospital between 2002 and 2006.] [JOURNAL ARTICLE]
Pathol Biol (Paris) 2009 Oct 27.
Abstract | Full CitationPrevalence and antimicrobial susceptibility of Escherichia coli in outpatient urinary isolates in Izmir, Turkey.http://www.unboundmedicine.com/medline/ebm/record/19865064/full_citation/Prevalence_and_antimicrobial_susceptibility_of_Escherichia_coli_in_outpatient_urinary_isolates_in_Izmir_Turkey_Yilmaz N, Agus N, Gul Yurtsever S, et al. 
Prevalence and antimicrobial susceptibility of Escherichia coli in outpatient urinary isolates in Izmir, Turkey. [Journal Article]
Med Sci Monit 2009 Nov; 15(11):PI61-65.
Abstract | Full CitationCombination testing of multidrug-resistant cystic fibrosis isolates of Pseudomonas aeruginosa: use of a new parameter, the susceptible breakpoint index.http://www.unboundmedicine.com/medline/ebm/record/19861334/full_citation/Combination_testing_of_multidrug_resistant_cystic_fibrosis_isolates_of_Pseudomonas_aeruginosa:_use_of_a_new_parameter_the_susceptible_breakpoint_index_Milne KE, Gould IM 
Combination testing of multidrug-resistant cystic fibrosis isolates of Pseudomonas aeruginosa: use of a new parameter, the susceptible breakpoint index. [JOURNAL ARTICLE]
J Antimicrob Chemother 2009 Oct 27.
Abstract | Full CitationIdentification of Optimal Renal Dosage Adjustments for Traditional and Extended Infusion Piperacillin/Tazobactam Dosing Regimens in Hospitalized Patients.http://www.unboundmedicine.com/medline/ebm/record/19858253/full_citation/Identification_of_Optimal_Renal_Dosage_Adjustments_for_Traditional_and_Extended_Infusion_Piperacillin/Tazobactam_Dosing_Regimens_in_Hospitalized_Patients_Patel N, Scheetz MH, Drusano GL, et al. 
Identification of Optimal Renal Dosage Adjustments for Traditional and Extended Infusion Piperacillin/Tazobactam Dosing Regimens in Hospitalized Patients. [JOURNAL ARTICLE]
Antimicrob Agents Chemother 2009 Oct 26.
Abstract | Full Citation | Find Related Articles